# OnCo record nct04270591 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04270591/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04270591", "NCT04270591" ;
  schema:name "Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer"@en ;
  schema:description "A phase 1/2 trial of Glumetinib in non-small-cell lung cancer, run by Haihe Biopharma Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04270591/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04270591> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2019-07-15" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/met-altered-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/glumetinib/> ;
  onco:companies <https://onco.cc/companies/haihe-biopharma/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct04270591-eclinicalmedicine-2023/>, <https://onco.cc/key-papers/paper-nct04270591-transl-lung-cancer-res-2025-update/> .